NCT04608032

Brief Summary

This study evaluates the effect of a cognitive remediation program on neurocognitive, social cognitive and metacognitive functions designed for patients living with a schizophrenia spectrum disorder.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 8, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 29, 2020

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

February 9, 2024

Status Verified

February 1, 2024

Enrollment Period

4.2 years

First QC Date

October 23, 2020

Last Update Submit

February 7, 2024

Conditions

Keywords

SchizophreniaNeurocognitionSocial cognitionMetacognitionCognitive remediation

Outcome Measures

Primary Outcomes (6)

  • STROOP

    Interference score

    pre-inclusion

  • TMTB

    Trail Making Test

    pre-inclusion

  • Litteral score of Verbal fluences

    Litteral score of Verbal fluences

    pre-inclusion

  • GO/NOGO

    cognitive control score

    pre-inclusion

  • tower of Hanoi

    Tower planning total score from tower of Hanoi

    pre-inclusion

  • Matrix test (WAIS-IV)

    The perceptual reasoning score of the Matrix test.

    pre-inclusion

Secondary Outcomes (37)

  • Mini-500

    pre-inclusion

  • CTQ

    pre-inclusion

  • PANSS

    pre-inclusion

  • EESEP

    Eighteen week

  • EESEP

    Twenty six week

  • +32 more secondary outcomes

Other Outcomes (44)

  • FAUX-PAS Test

    First week

  • FAUX-PAS Test

    Ten week week

  • FAUX-PAS Test

    Eighteen week week

  • +41 more other outcomes

Study Arms (2)

Ecological Cognitive training program for schizophrenia spectrum disorder [ECo-Sz]

EXPERIMENTAL

To inform the patient about cognitive impairments and their repercussions ; to train the patient in problem-solving skills through exercices ; to implement strategies in daily life. Duration : two month. Frequency : Two one hour individual sessions and one hour of at-home training per week. Modalities : pen and papers exercices (tools, token, cards, maps and chessboard). Modules : Psychoeducation, Attention, Memory, Executive functions, Social cognition and metacognition, Functional impairments

Other: [Eco-Sz] Ecological Cognitive training program for schizophrenia spectrum disorder

[THoR] Recovery-Oriented Therapy

ACTIVE COMPARATOR

Individual psychotherapy sessions focussing on autonomy in daily life, management of mood disorders' and functional impact, social skills, motivation and the regulation of sleep and daily activities

Other: Recovery-Oriented Therapy

Interventions

The first group will have \[Eco-Sz\] Ecological Cognitive training program for schizophrenia spectrum disorder

Also known as: [Eco-Sz]
Ecological Cognitive training program for schizophrenia spectrum disorder [ECo-Sz]

The second group will have \[THoR\] Recovery-Oriented Therapy

Also known as: [THoR]
[THoR] Recovery-Oriented Therapy

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Schizophrenia Disorder diagnosis, according to Diagnostic and Statistical Manual of mental disorders - Fifth edition (DSM-V) - Patient stabilized in terms of positive and negative symptomatology (absence or presence of weak positive and negative symptoms)
  • Positive and Negative stable symptoms (no or few positive and negative symptoms)
  • Stable and effective minimum dose of medication (antipsychotic) for the last three months
  • Cognitive complaint expressed by the patient
  • Informed consent form read, initialed and signed
  • Understanding of spoken and read French
  • Patient registered on the social welfare system

You may not qualify if:

  • Other diagnosis at the forefront than Schizophrenia of the DSM-V
  • Medical history neurological disorder resulting in hospitalization
  • Acute episode in the last three month
  • Somatic disorders resulting in cognitive impairment
  • Engagement in a research protocol either currently or over the last month
  • Neuropsychological assessment evaluation during the last six month
  • Patients under the protection of a conservator (simple or reinforced)
  • Individuals in vulnerable circumstances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ch Ville Evrard

Neuilly-sur-Marne, 93330, France

RECRUITING

URC Ville Evrard

Neuilly-sur-Marne, 93330, France

RECRUITING

MeSH Terms

Conditions

Schizophrenia

Interventions

Thor protein, Drosophila

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • ClĂ©mence ISAAC, PHD

    URC EPS Ville Evrard

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dominique JANUEL, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The first group is about cognitive remediation therapy (ECo-Sz). The second group is about recovery oriented therapy (ThOR).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 23, 2020

First Posted

October 29, 2020

Study Start

September 8, 2020

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

February 9, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations